Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06016712
Other study ID # EK-VP/55l012022
Secondary ID Internal hospita
Status Recruiting
Phase N/A
First received
Last updated
Start date August 8, 2023
Est. completion date December 31, 2024

Study information

Verified date February 2024
Source Faculty Hospital Kralovske Vinohrady
Contact Jan Zapletal, MD
Phone +420607882602
Email honza.zaple@seznam.cz
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Glaucoma is a multifactorial disease, an important risk factor of which is increased intraocular pressure. Fluctuations in intraocular pressure are often associated with vaginal birth, although intraocular pressure during active pushing during stage II has never been measured.. The study will be conducted on a group of patients with healthy eyes on patients who have completely fine vision or have a small refractive error and are accustomed to wearing contact lenses. The measurement of intraocular pressure itself will be carried out using SENSIMED Triggerfish contact lenses, which measure pressure every 5 minutes for 30s. This period roughly corresponds to the duration of 1-2 contractions. Inclusion in the study will be offered to patients in the 35th to 37th week of pregnancy. Prior to measurement patients will be sent to an eye clinic for a detailed examination of both eyes, which includes measuring intraocular pressure. Subsequently, pregnancy checks will take place according to the standard scheme and in the standard scope. At the onset of uterine contractions, an ophthalmologic consultant will be called, which will measure intraocular pressure between contractions using the Tonopen device and put on SENSIMED Trigerfish contact lenses in combination with a local anesthetic. The patient will have these lenses until the end of the third stage of labor, i.e. 2 hours after the birth, when the lenses are removed. In the second stage of labor, continuous monitoring by a cardiotocograph will take place. Subsequently, the obtained data from the cardiotocograph and contact lenses will be evaluated and compared by a team of ophthalmologists and gynecologists, where the investigators will be able to assess the individual fluctuations in intraocular pressure depending on the individual contractions. The aim of the study is to demonstrate or disprove the risks to the glaucoma patient due to increased intraocular pressure during active pushing in combination with uterine contraction.


Description:

Glaucoma is a multifactorial disease, an important risk factor of which is increased intraocular pressure. Fluctuations in intraocular pressure are often associated with vaginal birth, although intraocular pressure during active pushing during stage II has never been measured. The study will be conducted on a group of patients with healthy eyes on patients who have completely fine vision or have a small refractive error and are accustomed to wearing contact lenses. The measurement of intraocular pressure itself will be carried out using SENSIMED Triggerfish contact lenses, which measure pressure every 5 minutes for 30s. This period roughly corresponds to the duration of 1-2 contractions. Inclusion in the study will be offered to patients in the 35th to 37th week of pregnancy.Prior to measurement patients will be sent to an eye clinic for a detailed examination of both eyes, which includes measuring intraocular pressure. Subsequently, pregnancy checks will take place according to the standard scheme and in the standard scope. At the onset of uterine contractions, an ophthalmologic consultant will be called, which will measure intraocular pressure between contractions using the Tonopen device and put on SENSIMED Trigerfish contact lenses in combination with a local anesthetic. The patient will have these lenses until the end of the third stage of labor, i.e. 2 hours after the birth, when the lenses are removed. In the second stage of labor, continuous monitoring by a cardiotocograph will take place. Subsequently, the obtained data from the cardiotocograph and contact lenses will be evaluated and compared by a team of ophthalmologists and gynecologists, where the investigators will be able to assess the individual fluctuations in intraocular pressure depending on the individual contractions. The aim of the study is to demonstrate or disprove the risks to the glaucoma patient due to increased intraocular pressure during active pushing in combination with uterine contraction.


Recruitment information / eligibility

Status Recruiting
Enrollment 9
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - physiological pregnancy - primiparous women Exclusion Criteria: - multiparous women - pathological pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
SENSIMED Triggerfish Eye Lenses
Contact lenses used for measuring intraocular pressure.

Locations

Country Name City State
Czechia Faculty Hospital Kralovske Vinohrady Praha

Sponsors (1)

Lead Sponsor Collaborator
Faculty Hospital Kralovske Vinohrady

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fluctuation of Intraocular pressure Investigators will use SENSIMED Triggerfish Lenses - contact lenses used for measuring intraocular pressure. Lenses are sending detailed description of intraocular pressure in regular time range. Measurements are then send to the software which compares all collected data. From start of regular contractions for the length of 24 hours (at least 2 hours after delivery if patient complies about the lenses)
Primary Rate of Uterine contractions Cardiotocography will be used for measuring regular uterine activity. Tocography will be used for evaluation of uterine activity compared to intraocular pressure Continuous CTG will be done during II phase of delivery and at least every 2 hours durins I phase of delivery
See also
  Status Clinical Trial Phase
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT03016234 - IOP Changes With Different Anesthetic Agents During Laparoscopic Colorectal Surgery N/A
Completed NCT04863209 - Effect of Osteopathic Techiniques on Intraocular Pressure N/A
Completed NCT02646033 - Quantitative Rise in Intraocular Pressure in Steep Trendelenburg Position
Completed NCT03139708 - The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients Phase 1
Recruiting NCT02697825 - Intraocular Pressure Versus Optic Nerve Sheath Diameter N/A
Completed NCT02985567 - An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children N/A
Withdrawn NCT00837226 - Effects of Weight Loss From Bariatric Surgery on Intraocular Pressure (IOP) N/A
Completed NCT02136589 - Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes Phase 4
Completed NCT03123614 - Loteprednol vs. Prednisolone and Fluorometholone Phase 4
Completed NCT05763056 - Effects of Intubation on Intra-ocular Pressure and Optic Nerve Sheath Diameter N/A
Completed NCT03359200 - Analysis of the Microbiota in Goldmann Applanation Tonometers at a Reference Service in Goiânia N/A
Completed NCT02816905 - Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery Phase 4
Withdrawn NCT02558309 - Optic Nerve Head Quantification While Reducing Elevated Intracranial Pressure N/A
Completed NCT01786954 - iCare vs Tonopen vs Goldmann Applanation Post-vitrectomy Surgery N/A
Completed NCT00552019 - Intraocular Pressure (IOP) Assessed by Dynamic Contour Tonometer (DCT) and Goldman Applanation Tonometry (GAT) N/A
Completed NCT00428740 - Long-Term IOP Fluctuation and VF Progression After Triple Procedure N/A
Completed NCT04360369 - Comparison of Intraocular Pressure Measurements Between Reichert Tono-Vera Tonometer and Goldmann Tonometry N/A
Completed NCT04521140 - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery Phase 4
Completed NCT05167773 - Clinical Study of the Topcon Tonometer TRK-3